Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors
{{output}}
The bromodomain-containing protein 4 (BRD4) has gained growing interest as an effective drug target for the treatment of hepatocellular carcinoma (HCC). Herein, we designed and synthesized a series of quinoxalinone derivatives as BRD4 inhibitors via scaffold h... ...
